BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21576601)

  • 1. Transplant tolerance: bench to bedside--26th annual Samuel Jason Mixter Lecture.
    Sachs DH
    Arch Surg; 2011 May; 146(5):501-5. PubMed ID: 21576601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costimulatory blockade for induction of mixed chimerism and renal allograft tolerance in nonhuman primates.
    Kawai T; Abrahamian G; Sogawa H; Wee S; Boskovic S; Andrew D; Nadazdin O; Mauiyyedi S; Weymouth D; Ko D; Colvin R; Sachs D; Cosimi A
    Transplant Proc; 2001; 33(1-2):221-2. PubMed ID: 11266787
    [No Abstract]   [Full Text] [Related]  

  • 3. Transplantation tolerance: the concept and its applicability.
    Dong VM; Womer KL; Sayegh MH
    Pediatr Transplant; 1999 Aug; 3(3):181-92. PubMed ID: 10487277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab in pediatric renal transplantation: a treatment for allograft rejection with B-cell infiltrates?
    Zand MS
    Am J Transplant; 2008 Dec; 8(12):2489-90. PubMed ID: 19032220
    [No Abstract]   [Full Text] [Related]  

  • 5. A clinically feasible approach to induce delayed tolerance in recipients of prior kidney or vascularized composite allotransplants.
    Chen B; Xu H; Corbin DR; Ildstad ST
    Transplantation; 2012 Oct; 94(7):671-8. PubMed ID: 22948444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal transplantation without immunosuppression in a host with tolerance induced by allogeneic bone marrow transplantation.
    Helg C; Chapuis B; Bolle JF; Morel P; Salomon D; Roux E; Antonioli V; Jeannet M; Leski M
    Transplantation; 1994 Dec; 58(12):1420-2. PubMed ID: 7809937
    [No Abstract]   [Full Text] [Related]  

  • 7. Reviewing the mechanism of peripheral tolerance in clinical transplantation.
    Suciu-Foca N; Cortesini R
    Contrib Nephrol; 2005; 146():132-142. PubMed ID: 15567927
    [No Abstract]   [Full Text] [Related]  

  • 8. Tolerance and chimerism after renal and hematopoietic-cell transplantation.
    Scandling JD; Busque S; Dejbakhsh-Jones S; Benike C; Millan MT; Shizuru JA; Hoppe RT; Lowsky R; Engleman EG; Strober S
    N Engl J Med; 2008 Jan; 358(4):362-8. PubMed ID: 18216356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploiting tolerance processes in transplantation.
    Waldmann H; Cobbold S
    Science; 2004 Jul; 305(5681):209-12. PubMed ID: 15247471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-mismatched renal transplantation without maintenance immunosuppression.
    Kawai T; Cosimi AB; Spitzer TR; Tolkoff-Rubin N; Suthanthiran M; Saidman SL; Shaffer J; Preffer FI; Ding R; Sharma V; Fishman JA; Dey B; Ko DS; Hertl M; Goes NB; Wong W; Williams WW; Colvin RB; Sykes M; Sachs DH
    N Engl J Med; 2008 Jan; 358(4):353-61. PubMed ID: 18216355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive drugs for kidney transplantation.
    Halloran PF
    N Engl J Med; 2004 Dec; 351(26):2715-29. PubMed ID: 15616206
    [No Abstract]   [Full Text] [Related]  

  • 12. As originally published in 1994: Development of tolerance to experimental cardiac allograft in utero. Updated in 2001.
    DiSesa VJ; Mohiuddin MM
    Ann Thorac Surg; 2001 Feb; 71(2):755-6. PubMed ID: 11235756
    [No Abstract]   [Full Text] [Related]  

  • 13. Spontaneous and iatrogenically augmented leukocyte chimerism in organ transplant recipients.
    Starzl TE; Demetris AJ; Rao AS; Thomson AW; Trucco M; Murase N; Zeevi A; Fontes P
    Transplant Proc; 1994 Oct; 26(5):3071-6. PubMed ID: 7940965
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-B cell therapy with rituximab as induction therapy in renal transplantation.
    Joosten I; Baas MC; Kamburova EG; van den Hoogen MW; Koenen HJ; Hilbrands LB
    Transpl Immunol; 2014 Oct; 31(4):207-9. PubMed ID: 25270152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive therapy and tolerance of organ allografts.
    Starzl TE
    N Engl J Med; 2008 Jan; 358(4):407-11. PubMed ID: 18216363
    [No Abstract]   [Full Text] [Related]  

  • 16. Donor chimera model for tolerance induction in transplantation.
    Rezaee F; Peppelenbosch M; Dashty M
    Hum Immunol; 2013 May; 74(5):550-6. PubMed ID: 23354322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of kidney allograft tolerance through mixed chimerism in miniature swine.
    Fuchimoto Y; Huang CA; Yamada K; Gleit ZL; Kitamura H; Griesemer A; Scheier-Dolberg R; Melendy E; White-Scharf ME; Sachs DH
    Transplant Proc; 2001; 33(1-2):77. PubMed ID: 11266710
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of donor chimerism, alloreactive host T cells and memory cell development in thymi from mice resistant to neonatal transplantation tolerance.
    Ruiz P; Nassiri M; Viciana AL; Padmanabhan J; Streilein JW
    J Immunol; 1995 Jan; 154(2):633-43. PubMed ID: 7814872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance can be infectious.
    Waldmann H
    Nat Immunol; 2008 Sep; 9(9):1001-3. PubMed ID: 18711438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune modulation in organ allograft recipients by single or multiple donor bone marrow infusions.
    Rao AS; Shapiro R; Corry R; Dodson F; Abu-Elmagd K; Pham S; Jordan M; Salgar S; Zeevi A; Rastellini C; Ostrowski L; Aitouche A; Keenan R; Reyes J; Griffith B; Starzl TE; Fung JJ
    Transplant Proc; 1999; 31(1-2):700-1. PubMed ID: 10083302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.